Discontinued — last reported Q4 '17
Finite Lived Intangible Assets - Gross
Gilead Sciences Finite Lived Intangible Assets - Gross remained flat by 0.0% to $31.88B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.0%, from $31.88B to $31.88B. Over 4 years (FY 2020 to FY 2024), Finite Lived Intangible Assets - Gross shows an upward trend with a 8.6% CAGR.
Analysis
How to read this metric
An increase typically signals recent strategic acquisitions or significant investment in intellectual property, while a decrease reflects asset retirement or impairment.
Detailed definition
This is the total historical cost of intangible assets with a defined useful life, such as patents, trademarks, and acqu...
Peer comparison
Large healthcare companies frequently carry significant gross intangible assets due to the high volume of M&A activity in the sector.
finite_lived_intangible_assets_grossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.72B | $25.72B | $25.92B | $25.94B | $25.92B | $25.92B | $25.79B | $31.89B | $31.89B | $31.89B | $31.82B | $31.82B | $31.82B | $31.88B | $31.88B | $31.88B | $31.88B | $31.88B |
| QoQ Change | — | +0.0% | +0.8% | +0.1% | -0.1% | +0.0% | -0.5% | +23.6% | +0.0% | +0.0% | -0.2% | +0.0% | +0.0% | +0.2% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.8% | +0.8% | -0.5% | +23.0% | +23.1% | +23.1% | +23.4% | -0.2% | -0.2% | -0.0% | +0.2% | +0.2% | +0.2% | +0.0% |
Finite Lived Intangible Assets - Gross at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's finite lived intangible assets - gross?
- Gilead Sciences (GILD) reported finite lived intangible assets - gross of $31.88B in Q3 2025.
- How has Gilead Sciences's finite lived intangible assets - gross changed year-over-year?
- Gilead Sciences's finite lived intangible assets - gross increased by 0.0% year-over-year, from $31.88B to $31.88B.
- What is the long-term trend for Gilead Sciences's finite lived intangible assets - gross?
- Over 4 years (2020 to 2024), Gilead Sciences's finite lived intangible assets - gross has grown at a 8.6% compound annual growth rate (CAGR), from $22.90B to $31.88B.
- What does finite lived intangible assets - gross mean?
- The total original cost of intangible assets that have a limited lifespan, before subtracting accumulated amortization.